Skip to main content

Nutrition in hepatic failure and liver transplantation

Abstract

Protein-energy malnutrition (PEM) is a common problem in patients with end-stage liver disease, and it is universally present in patients undergoing orthotopic liver transplantation. Although PEM is an independent risk factor for morbidity and mortality, it need not be considered an absolute contraindication for liver transplantation. The etiology of PEM in liver disease is multifactorial and includes decreased nutrient and calorie intake, alterations in intestinal malabsorption and/or maldigestion, and diverse abnormalities of carbohydrate, fat, and protein metabolism. This article reviews the prevalence of malnutrition, its pathophysiology, different modalities for assessment of body composition, and general guidelines for nutritional support in patients with liver disease and liver transplantation.

This is a preview of subscription content, access via your institution.

References and Recommended Reading

  1. Prijatmoko D, Strauss BJ, Lambert JR, et al.: Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis. Gastroenterology 1993, 105:1839–1845.

    PubMed  CAS  Google Scholar 

  2. McCullough AJ, Bugianesi E: Protein calorie malnutrition and the etiology of cirrhosis. Am J Gastroenterol 1997, 92:734–738.

    PubMed  CAS  Google Scholar 

  3. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis: Nutritional status in cirrhosis. J Hepatol 1994 21:317–325.

    Article  Google Scholar 

  4. Marsano L, McClain CJ: Nutrition and alcoholic liver disease. JPEN J Paranter Enteral Nutr 1991, 15:337–344.

    CAS  Google Scholar 

  5. Mendenhall CL, Moritz TE, Roselle GA, et al.: Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275. JPEN J Parenter Enteral Nutr 1995,19:258–265.

    PubMed  CAS  Google Scholar 

  6. Lautz HU, Selberg O, Korber J, et al.: Protein-calorie malnutrition in liver cirrhosis. Clin Invest 1992, 70:478–486.

    Article  CAS  Google Scholar 

  7. DiCecco SR, Wieners EJ, Wiesner RH, et al.: Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantation. Mayo Clin Proc 1989, 64:95–102.

    PubMed  CAS  Google Scholar 

  8. Hasse JM: Nutritional implications of liver transplantation. Henry Ford Hosp Med J 1990, 38:235–240.

    PubMed  CAS  Google Scholar 

  9. Hehir DJ, Jenkins RL, Bistrian BR, Blackburn GL: Nutrition in patients undergoing orthotopic liver transplant. JPEN J Parenter Enteral Nutr 1985, 9:695–700.

    PubMed  CAS  Google Scholar 

  10. Lochs H, Plauth M: Liver cirrhosis: rationale and modalities for nutritional support—the European Society of Parenteral and Enteral Nutrition consensus and beyond. Curr Opin Clin Nutr Metab Care 1999, 2:345–349.

    PubMed  Article  CAS  Google Scholar 

  11. Lowell JA: Nutritional assessment and therapy in patients requiring liver transplantation. Liver Transpl Surg 1996, 2 (suppl 1):79–88.

    PubMed  CAS  Google Scholar 

  12. Richardson RA, Davidson HI, Hinds A, et al.: Influence of the metabolic sequelae of liver cirrhosis on nutritional intake. Am J Clin Nutr 1999, 69:331–337.

    PubMed  CAS  Google Scholar 

  13. Miki C, Iriyama K, Mayer AD, et al.: Energy storage and cytokine response in patients undergoing liver transplantation. Cytokine 1999, 11:244–248.

    PubMed  Article  CAS  Google Scholar 

  14. McCullough AJ, Bugianesi E, Marchesini G, Kalhan SC: Genderdependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology 1998, 115:947–953.

    PubMed  Article  CAS  Google Scholar 

  15. Testa R, Franceschini R, Giannini E, et al.: Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. J Hepatol 2000, 33:33–37.

    PubMed  Article  CAS  Google Scholar 

  16. Greco AV, Mingrone G, Benedetti G, et al.: Daily energy and substrate metabolism in patients with cirrhosis. Hepatology 1998, 27:346–350.

    PubMed  Article  CAS  Google Scholar 

  17. Muller MJ, Pirlich M, Balks HJ, Selberg O: Glucose intolerance in liver cirrhosis: role of hepatic and non-hepatic influences. Eur J Clin Chem Clin Biochem 1994, 32:749–758.

    PubMed  CAS  Google Scholar 

  18. Marchesini G, Ronchi M, Forlani G, et al.: Cardiovascular disease in cirrhosis: a point-prevalence study in relation to glucose tolerance. Am J Gastroenterol 1999, 94:655–662.

    PubMed  CAS  Google Scholar 

  19. McCullough AJ, Tavill AS: Disordered energy and protein metabolism in liver disease. Semin Liver Dis 1991, 11:265–277.

    PubMed  CAS  Google Scholar 

  20. Druml W, Fischer M, Pidlich J, Lenz K: Fat elimination in chronic hepatic failure: long-chain vs medium-chain triglycerides. Am J Clin Nutr 1995, 61:812–817.

    PubMed  CAS  Google Scholar 

  21. Cabre E, Abad-Lacruz A, Nunez MC, et al.: The relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis: multivariate analysis. Am J Gastroenterol 1993, 88:718–722.

    PubMed  CAS  Google Scholar 

  22. Cabre E, Nunez M, Gonzalez-Huix F, et al.: Clinical and nutritional factors predictive of plasma lipid unsaturation deficiency in advanced liver cirrhosis: a logistic regression analysis. Am J Gastroenterol 1993, 88:1738–1743.

    PubMed  CAS  Google Scholar 

  23. McCullough AJ, Mullen KD, Kalhan SC: Defective nonoxidative leucine degradation and endogenous leucine flux in cirrhosis during an amino acid infusion. Hepatology 1998, 28:1357–1364. Report from an elegant study of leucine kinetics in cirrhotic patients during amino acid infusion. This study shows that leucine is oxidized completely, and therefore, that less leucine is available for other metabolic pathways.

    PubMed  Article  CAS  Google Scholar 

  24. Mullen KD, Denne SC, McCullough AJ, et al.: Leucine metabolism in stable cirrhosis. Hepatology 1986, 6:622–630.

    PubMed  Article  CAS  Google Scholar 

  25. Kondrup J, Nielsen K, Juul A: Effect of long-term refeeding on protein metabolism in patients with cirrhosis of the liver. Br J Nutr 1997, 77:197–212.

    PubMed  Article  CAS  Google Scholar 

  26. Nielsen K, Kondrup J, Martinsen L, et al.: Long-term oral refeeding of patients with cirrhosis of the liver. Br J Nutr 1995, 74:557–567.

    PubMed  Article  CAS  Google Scholar 

  27. Weber FL, Bagby BS, Licate L, Kelsen SG: Effects of branchedchain amino acids on nitrogen metabolism in patients with cirrhosis. Hepatology 1990, 11:942–950.

    PubMed  Article  Google Scholar 

  28. Fabbri A, Magrini N, Bianchi G, et al.: Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy. JPEN J Parenter Enteral Nutr 1996, 20:159–164.

    PubMed  CAS  Google Scholar 

  29. DerSimonian R: Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy: meta-analysis. Hepatology 1990, 11:1083–1084.

    PubMed  Article  CAS  Google Scholar 

  30. Berlin JA, Chalmers TC: Meta-analysis of branched-chain amino acids in hepatic encephalopathy. Gastroenterology 1989, 97:1043–1045.

    PubMed  CAS  Google Scholar 

  31. Naylor CD, O’Rourke K, Detsky AS, Baker JP: Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy: a meta-analysis. Gastroenterology 1989, 97:1033–1042.

    PubMed  CAS  Google Scholar 

  32. Chin SE, Shepherd RW, Thomas BJ, et al.: Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement. Am J Clin Nutr 1992, 56:158–163.

    PubMed  CAS  Google Scholar 

  33. Zoli M, Marchesini G, Dondi C, et al.: Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting. Clin Sci 1982, 62:683–686.

    PubMed  CAS  Google Scholar 

  34. Andersen H, Borre M, Jakobsen J, et al.: Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy. Hepatology 1998, 27:1200–1206. Interesting study of muscle strength showing that muscle function is related to malnutrition and not to severity of liver disease or to neuropathy in alcoholic liver disease.

    PubMed  Article  CAS  Google Scholar 

  35. McCullough AJ, Raguso C: Effect of cirrhosis on energy expenditure. Am J Clin Nutr 1999, 69:1066–1068.

    PubMed  CAS  Google Scholar 

  36. Muller MJ, Bottcher J, Selberg O, et al.: Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr 1999, 69:1194–1201.

    PubMed  CAS  Google Scholar 

  37. Muller MJ, Lautz HU, Plogmann B, et al.: Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992, 15:782–794.

    PubMed  Article  CAS  Google Scholar 

  38. Selberg O, Bottcher J, Tusch G, et al.: Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997, 25:652–657. This very interesting study identifies patients according to high or low risk for survival after liver transplantation based on metabolic rate and body cell mass.

    PubMed  Article  CAS  Google Scholar 

  39. Marchesini G, Fabbri A, Bianchi G, et al.: Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology 1996, 23:1084–1092.

    PubMed  Article  CAS  Google Scholar 

  40. Floreani A, Baragiotta A, Martines D, et al.: Plasma antioxidant levels in chronic cholestatic liver diseases. Aliment Pharmacol Ther 2000, 14:353–358.

    PubMed  Article  CAS  Google Scholar 

  41. Trautwein C, Possienke M, Schlitt HJ, et al.: Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol 2000, 95:2343–2351.

    PubMed  Article  CAS  Google Scholar 

  42. Hasse J, Strong S, Gorman MA, Liepa G: Subjective global assessment: alternative nutrition-assessment technique for liver-transplant candidates. Nutrition 1993, 9:339–343.

    PubMed  CAS  Google Scholar 

  43. Naveau S, Belda E, Borotto E, et al.: Comparison of clinical judgment and anthropometric parameters for evaluating nutritional status in patients with alcoholic liver disease. J Hepatol 1995, 23:234–235.

    PubMed  Article  CAS  Google Scholar 

  44. Nielsen K, Kondrup J, Martinsen L, et al.: Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis. Br J Nutr 1993, 69:665–679.

    PubMed  Article  CAS  Google Scholar 

  45. Pirlich M, Selberg O, Boker K, et al.: The creatinine approach to estimate skeletal muscle mass in patients with cirrhosis. Hepatology 1996, 24:1422–1427. This article shows that 24-hour urinary creatinine excretion is a good measurement of body cell mass (muscle) and also that this test correlates well with other body cell mass measurements.

    PubMed  Article  CAS  Google Scholar 

  46. Schloerb PR, Forster J, Delcore R, Kindscher JD: Bioelectrical impedance in the clinical evaluation of liver disease. Am J Clin Nutr 1996,64(suppl 3):510S-514S.

    PubMed  CAS  Google Scholar 

  47. Zillikens MC, van den Berg JW, Wilson JH, Swart GR: Whole-body and segmental bioelectrical-impedance analysis in patients with cirrhosis of the liver: changes after treatment of ascites. Am J Clin Nutr 1992, 55:621–625.

    PubMed  CAS  Google Scholar 

  48. Pirlich M, Schutz T, Spachos T, et al.: Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000, 32:1208–1215. Interesting study showing that BIA may be a reliable tool for determination of body cell mass despite the presence of ascites.

    PubMed  Article  CAS  Google Scholar 

  49. Fiore P, Merli M, Andreoli A, et al.: A comparison of skinfold anthropometry and dual-energy X-ray absorptiometry for the evaluation of body fat in cirrhotic patients. Clin Nutr 1999, 18:349–351.

    PubMed  Article  CAS  Google Scholar 

  50. Madden AM, Morgan MY: Resting energy expenditure should be measured in patients with cirrhosis, not predicted. Hepatology 1999, 30:655–664.

    PubMed  Article  CAS  Google Scholar 

  51. Merli M, Riggio O, Dally L: Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology 1996, 23:1041–1046.

    PubMed  Article  CAS  Google Scholar 

  52. Shaw BW, Wood RP, Gordon RD, et al.: Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis 1985, 5:385–393.

    PubMed  Google Scholar 

  53. Miki C, Iriyama K, Mayer AD, et al.: Energy storage and cytokine response in patients undergoing liver transplantation. Cytokine 1999, 11:244–248.

    PubMed  Article  CAS  Google Scholar 

  54. Moller S, Bendtsen F, Christensen E, Henriksen JH: Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding. J Hepatol 1994, 21:940–946.

    PubMed  Article  CAS  Google Scholar 

  55. Cabre E, Gonzalez-Huix F, Abad-Lacruz A, et al.: Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics: a randomized controlled trial. Gastroenterology 1990, 98:715–720. One of the few studies showing that enteral nutrition is safe and effective in improving the short-term clinical outcome in severely malnourished cirrhotics.

    PubMed  CAS  Google Scholar 

  56. Hasse JM, Blue LS, Liepa GU, et al.: Early enteral nutrition support in patients undergoing liver transplantation. JPEN J Parenter Enteral Nutr 1995, 19:437–443.

    PubMed  CAS  Article  Google Scholar 

  57. Wicks C, Somasundaram S, Bjarnason I, et al.: Comparison of enteral feeding and total parenteral nutrition after liver transplantation. Lancet 1994, 24:837–840.

    Article  Google Scholar 

  58. Mezey E, Caballeria J, Mitchell MC, et al.: Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial. Hepatology 1991, 14:1090–1096.

    PubMed  CAS  Article  Google Scholar 

  59. Weimann A, Kuse ER, Bechstein WO, et al.: Perioperative parenteral and enteral nutrition for patients undergoing orthotopic liver transplantation: results of a questionnaire from 16 European transplant units. Transpl Int 1998, 11(suppl 1):S289-S291.

    PubMed  Article  Google Scholar 

  60. Mendenhall CL, Moritz TE, Roselle GA, et al.: A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 1993, 17:564–576.

    PubMed  Article  CAS  Google Scholar 

  61. Trautwein C, Possienke M, Schlitt HJ, et al.: Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol 2000, 95:2343–2351.

    PubMed  Article  CAS  Google Scholar 

  62. Heathcote J: Osteoporosis in chronic liver disease. Curr Gastroenterol Rep 1999, 1:455–458.

    PubMed  Article  CAS  Google Scholar 

  63. Poonawala A, Nair SP, Thuluvath PJ: Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000, 32:689–692.

    PubMed  Article  CAS  Google Scholar 

  64. Caldwell SH, Oelsner DH, Iezzoni JC, et al.: Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999, 29:664–669.

    PubMed  Article  CAS  Google Scholar 

  65. Sawyer RG, Pelletier SJ, Pruett TL: Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transplant 1999, 13:126–130.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Aranda-Michel, J. Nutrition in hepatic failure and liver transplantation. Curr Gastroenterol Rep 3, 362–370 (2001). https://doi.org/10.1007/s11894-001-0061-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-001-0061-0

Keywords

  • Liver Disease
  • Liver Transplantation
  • Chronic Liver Disease
  • Hepatic Encephalopathy
  • Nutritional Support